With the sensitivity of these HNSCC cell lines to IL-13-PE, we decided to test this immunotoxin treatment in a genetically engineered mouse model of head and neck cancer, the Tgfbr1/Pten 2cKO mice. The gene discussed is PTEN; the disease is head and neck cancer.